Burjeel Hospitals has introduced Trucheck™ intelli, an advanced, non-invasive blood test designed for the early detection of over 70 types of solid tumors. This breakthrough in diagnostic innovation marks a significant milestone in Burjeel Cancer Institute’s (BCI) mission to advance preventive cancer care and personalized medicine.
With cancer remaining the second leading cause of death globally, according to the World Health Organization (WHO), early detection is critical to improving survival rates. Trucheck™ intelli offers a transformative approach by identifying circulating tumor cells (CTCs) and molecular signatures linked to cancer, allowing clinicians to detect malignancies even before symptoms appear.
“Trucheck has demonstrated exceptional accuracy exceeding 95% in detecting cancers such as breast, lung, liver, pancreatic, thyroid, and gastrointestinal,” said Prof. Humaid Al Shamsi, CEO of Burjeel Cancer Institute (BCI). “Unlike conventional tests based on circulating tumor DNA (ctDNA) methylation patterns, Trucheck focuses on intact tumor cells, which provide a more direct signal of malignancy and detailed cellular information.”
The test’s simplicity is one of its defining features—requiring no fasting or special preparation. It is particularly recommended for asymptomatic individuals aged 40 and above, those with a family history or genetic predisposition to cancer, and patients undergoing post-treatment monitoring. With rapid turnaround times, Trucheck™ intelli supports timely diagnosis and personalized treatment decisions, significantly reducing false positives and negatives.
“In cancer care, early diagnosis is the cornerstone—it changes everything,” added Dr. Al Shamsi. “By offering Trucheck, we aim to empower individuals with access to precise, preventive testing that can ultimately save lives and lessen the social and economic impact of cancer.”
With its potential to detect cancer at its earliest stages, Trucheck™ intelli represents a major advancement in non-invasive, preventive healthcare—redefining how cancer is detected, treated, and managed for a healthier, cancer-free future.
